Advanced Cell Diagnostics’ RNAscope® platform is becoming the method of choice for tissue-based gene expression analysis for target validation, target safety assessment and biomarker development. The RNAscope® assay is the most sensitive and most specific assay available for tissue-based expression analysis… Read More
BD is a global medical technology company that benefits countless lives worldwide. Our 45,000 associates help advance healthy by improving the ways that discovery, diagnostics and delivery of care are conducted – enhancing outcomes, better managing healthcare delivery costs, increasing efficiencies, improving healthcare safety and expanding patient access. Our product portfolio, leadership and partnerships help make a difference for global healthcare.
Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application.
Our more than 25 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 1,800 employees in 25 countries.
Vineti combines industry-leading software expertise with deep first-hand, knowledge of commercializing personalized cell therapies to digitize the supply chain, manufacturing and compliance systems for the delivery of transformational medicines. Vineti’s user-centric design creates a platform that is easier for physicians, nurses, and manufacturing operations to use, resulting in a superior user experience and reduced risk. The Vineti platform provides actionable insights to continually optimize the process, accelerating time to revenue and decreasing costs.
One Lambda, a brand of Thermo Fisher Scientific, is the global leader in transplant diagnostics. For over 30 years we have supported the global transplant community, improving the standard of care for transplant patients and their families. Our broad range of HLA typing and antibody detection products, instrumentation, and software support the management of transplant patients worldwide. One Lambda has an extensive line of monoclonal antibodies and hybridomas that cover the spectrum of HLA specificities.
Caprion provides GCP/GLP/GCLP immune monitoring and proteomics services to 50+ major companies in the pharmaceutical and biotechnology industry for their vaccine and immunotherapy programs. Caprion’s immune monitoring business unit, ImmuneCarta®, offers proprietary multiparametric flow cytometry for functional analyses of innate and adaptive immune responses…Read More
ChemoMetec is a Danish founded company, which specializes in development, manufacturing and sales of high quality automated Cell Counters, Advanced Cell Analyzers and Image Cytometers to help streamline research and production processes for maximum efficiency. ChemoMetec instruments are based on a patented, unique technology platform that ensures a high quality of analysis results and reliability. The instruments are known for their robustness and high precision as well as the … Read More
Fresenius Kabi is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. Through our recent acquisition of Fenwal, we bring over 60 years experience advancing the fields of cell collection and separation with a deep expertise in closed-system processing. We recently launched Lovo, the only cell processing system that washes and concentrates white blood cells using filtration technology, specifically to serve the needs of the cellular therapies community.
At GE Healthcare Life Sciences, we are on a mission to accelerate precision medicine by helping researchers and pharmaceutical companies to discover and make new therapies. We provide expertise and technology for a wide range of areas within the industry, including basic research, drug discovery and technologies to large-scale manufacturing of biopharmaceuticals and cell therapies.
Key Biologics provides biological products to the cell therapy industry worldwide. Non-mobilized and G-CSF mobilized MNC collections are performed under proprietary IRB-approved protocols. Three G-CSF schedules are available: 4day/10ug per kg/single collection, 5day/10ug per kg/single collection and 5day/5ug per kg/two collections. Key operates the Spectra, Optia and Amicus devices allowing customers to compare MNC product characteristics that could influence manufacturing of autologous or allogeneic cell-based therapies.